Newly synthesized pyrazolidine derivatives as potential activators of fibrinolysis and antiaggregating agents.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D010653:Phenylbutazone / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011720:Pyrazoles / Q000494:pharmacology*; D051381:Rats; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship
D000893:Anti-Inflammatory Agents; D011720:Pyrazoles; D000244:Adenosine Diphosphate; D010653:Phenylbutazone